News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies
Vivek Subbiah/LinkedIn
Apr 19, 2025, 08:05

Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on LinkedIn about recent paper he and his colleagues co-authored:

“Delighted to share our latest publication in American Society of Clinical Oncology (ASCO) Journal JCO Precision Oncology – courtesy of our brilliant colleagues from London led by Dr. Elisa Fontana.

FGFR is clearly a tissue-agnostic target but we need to find the right dose for the right patient with right alteration.

Thrilled to collaborate with amazing colleagues Tobias Arkenau, Charles Swanton.”

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials

Authors: Rafael Grochot, Tobias Arkenau, Charles Swanton, Vivek Subbiah, Elisa Fontana, et al.

Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies

More posts featuring Vivek Subbiah.

cancer Cancer research Charles Swanton Elisa Fontana OncoDaily Oncology Tobias Arkenau Vivek Subbiah
Special Coverage
Blog
May 21, 2025, 01:40
Teresa Amaral: 5th edition of YO Congress
Blog
May 20, 2025, 17:22
The Lancet Group's Editorial Team Will Be on the Ground at ASCO 2025
Blog
May 20, 2025, 17:11
Pam Traxel: One in Ten Cancer Survivors Rely on Medicaid - Cuts Have Consequences
Blog
May 20, 2025, 16:58
Elvina Majiwa and Murallitharan Munisamy Have Won The World No Tobacco Day Award - UICC
Blog
May 20, 2025, 16:56
PER Tumor Board: Applying Recent Advances to Transform the Treatment Paradigm in SCLC
Blog
May 20, 2025, 16:46
Shahrin Ahmed: Specific Pre-surgery Medication Improves Survival Rates in Hereditary Breast Cancer Cases
Blog
May 20, 2025, 16:43
Ahmed Magdy Rabea: Pleased to Give a Multiple Myeloma Awareness Session to the Pfizer Egypt Team
Blog
May 20, 2025, 16:37
Sachin Jain: The Greatest Impact of AI Will Come from Improving Care and Service
Blog
May 20, 2025, 16:27
It Is Time to Invest in Cancer Research - Stand Up To Cancer
Insight
May 20, 2025, 15:50
Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking
Blog
May 20, 2025, 15:37
Fumiko Ladd Chino: Even with Superlative Healthcare You Can Still End Up with Stage 4 Cancer
Blog
May 20, 2025, 15:20
Save the date for the 7th CCI4EU Online Course - "Early Cancer Detection, Screening, and Prevention"